共 25 条
[1]
Phillips P.S., Haas R.H., Bannykh S., Et al., Statin associated myopathy with normal creatine kinase levels, Ann. Intern. Med., 137, pp. 581-585, (2002)
[2]
Grundy S.M., Can statins cause chronic low grade myopathy?, Ann. Intern. Med., 137, pp. 617-618, (2002)
[3]
Farmer J.A., Torre-Antione G.T., Statins and myotoxicity: Potential mechanisms and clinical implications, Klin Forschung, 8, pp. 87-91, (2002)
[4]
Hargreaves I.P., Heales S., Statins and myopathy, Lancet, 359, pp. 711-712, (2002)
[5]
Laaksonen R., Jokelainen K., Sahi T., Et al., Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans, Clin. Pharmacol. Ther., 57, pp. 62-66, (1995)
[6]
Bleske B.E., Willis R.A., Anthony M., Et al., The effect of pravastatin and atorvastatin on coenzyme Q-10, Am. Heart J., 142, (2001)
[7]
Gruer P.J., Vega J.M., Mercuri M.S., Et al., Concomitant use of cytochrome P450 3A inhibitors and simvastatin, Am. J. Cardiol., 87, pp. 811-815, (1999)
[8]
Omar M.A., Wilson J.P., Cox T.S., Rhabdomyolysis and HMG Co A reductase Inhibitor, Ann. Pharmacother., 35, pp. 1096-1107, (2001)
[9]
Davidson M.H., Does differing metabolism by cytochrome P450 have clinical importance?, Curr. Atheroscler. Rep., 2, pp. 14-19, (2000)
[10]
Paoletti R., Corsini A., Bellosta S., Pharmacologic interactions with statins, Atherosclerosis, 3, SUPPL., pp. 35-40, (2002)